Introduction
The introduction of combination antiretroviral therapy (cART) for the treatment of HIV infection has dramatically altered the course of HIV/AIDS, prolonging life span to nearly normal and minimizing the risk for opportunistic infections (1) . Despite immune restoration of CD4 + T cells and improved immune profile with treatment, HIV-infected individuals remain at a higher risk for influenza infections compared with healthy individuals (2) and it is recommended that they receive seasonal influenza vaccinations on a yearly basis (3) .
It is well established that lymph node (LN) structure and cellularity are significantly altered in HIV (4, 5) and may not achieve normality (6, 7) . We and several groups have shown that the ability of HIV-infected individuals to mount adequate antibody responses to immunization may be compromised (8) (9) (10) (11) (12) (13) . However, the relevant LN immune dynamics in the context of HIV and cART remain unknown. T follicular helper (Tfh) cells are a highly specialized subset of CD4 + T cells that localize within the follicles and, more specifically, germinal centers (GC-Tfh) (14, 15) . Although the exact ontogeny of these cells remains controversial, several lines of evidence have established their role in B cell maturation, recombination, class switching, and antibody production (16-19) that occur via specific receptor-ligand interactions and cytokine production (20, 21). HIV and SIV infection result in accumulation of Tfh cells in LNs; these cells have been found to be highly permissive for HIV, which contributes to HIV persistence (22-24). Furthermore, significant changes of the Tfh cell gene signature (24) in LN and in the circulating peripheral counterparts of Tfh (pTfh) have been described in HIV infection (25, 26) . Given the heightened risk of HIV seropositive individuals for comorbid diseases and the need for less toxic treatment alternatives for long-term disease management, understanding tissue-specific immunity becomes increasingly important. We used seasonal influenza vaccination to study Tfh and B cell dynamics at lymphoid tissue levels in the context of ART-controlled chronic HIV infection. We show that LNs from HIV + individuals on cART are enriched for Tfh cells compared with LNs from healthy participants before vaccination and that Tfh cells are preferentially localized in follicles that maintain the FDC network architecture. In addition, the examination of Tfh cell frequencies in the context of response to vaccination revealed that prevaccination frequencies could predict the serologic response to the less frequently encountered influenza B antigen in our cohort. We further show that vaccination also induced a global reduction in the frequencies of Tfh cells in the LNs of HIV + participants. of pTfh cells at baseline using the gating strategy shown in Supplemental Figure 1D . We found a significantly higher frequency of PD-1 + pTfh cells in HIV + compared with HC participants (Supplemental Figure 1E ).
Results

LNs of HIV + patients on cART have higher frequencies of Tfh CD4 + T cells than those
Prevaccination Tfh numbers are higher in follicles with preserved FDC networks. cART partially reverses the tissue-associated follicular damage induced by HIV (35) . We investigated the follicular integrity in our samples by assessing the size of the follicular surface area, light zone/dark zone polarization, level of apoptosis, and FDC preservation. We applied multispectral confocal imaging and H&E staining to look at the follicular architecture of inguinal LNs obtained at study entry. Where applicable, tonsils from unrelated, unvaccinated HCs were also stained with the same panel as controls (Supplemental Figure 2A) . Although tonsils and LNs represent secondary lymphoid organs of different anatomical position and cellularity, B cell follicles from both tissue types display a highly similar GC topographical organization in the absence of immunopathology (36) . The inclusion of tonsils hence was used to guide, in conjunction with our findings from HC LNs, the mapping of topographical changes seen in HIV + participants. We found a higher degree of follicular GC heterogeneity in HIV + participants compared with HCs ( Figure 2A and Supplemental Figure 2A ). Even though some "canonical" secondary follicles with a well-defined mantle zone, as denoted by IgD staining and Ki67 polarization, could be seen (data not shown), the majority of follicles examined in HIV + LNs harbored IgD + zones that were less easy to define, if at all present, and without a clear GC Ki67 polarization (Figure 2A ). An ingression of mantle B cells (IgD + ) into the reactive GCs (Figure 2A ) was notable in HIV + LNs, and the size of follicles was also different between the 2 groups, with B cell areas covering a higher surface area in HIV + LNs than HCs, consistent with follicular hyperplasia and/or lysis ( Figure 2A and Supplemental Figure 2 , A and B) even after cART in HIV infection. The presence of follicular dendritic cell (FDC) networks was investigated by imaging analysis (see Methods). We found that higher absolute Tfh cell numbers correlated with follicles that had retained an FDC network, as calculated by surface area analysis (r 2 = 0.3647, P = 0.0023) ( Figure  2 , B and C). In addition, we employed an in situ cell death assay (TUNEL) that allows for the detection of dead cells with respect to their localization. We found lower levels of TUNEL + events in HC LN follicles (145 ± 224 cells/mm 2 versus 273 ± 271 for HIV + ) ( Figure 3 , A and B), consistent with a higher level of cellular death in follicles of HIV + participants. We opted for enumeration of total TUNEL + events per follicle, as the downregulation of cell surface markers during apoptosis precluded the measurement of cellular death within individual cell subsets. Our data show that, in treated HIV + infection, despite the presence of a generalized perturbation in follicular architecture, Tfh cell numbers are higher in those follicles that maintain a level of architectural integrity, as judged by the presence of FDCs.
Vaccination induces relevant follicular B cell populations. Next, the dynamics of follicular B cell populations before and after vaccination were investigated by applying a polychromatic flow cytometry panel for the detection of follicular B cell subsets, particularly those expressing the CD20 hi phenotype, an abundant B cell population within the GC. The gating strategy adopted for B cell phenotyping in LN cell suspension is shown in Figure   influenza vaccination (as summarized in Table 1 ) to investigate the impact of chronic HIV infection and cART upon the dynamics of subsequent CD4 + T cell mobilization. As shown in Figure  1A , we began the analysis at study entry by measuring the relative frequencies (%) of Tfh cells in draining inguinal LNs using a polychromatic flow cytometry assay using LN mononuclear cell (LNMC) suspension. The gating strategy adopted is shown in Figure 1B. Tfh CD4 + T cells were defined based on their high expression of PD-1 and CXCR5, both of which are classic markers of Tfh cells (27) . In addition, we dissected the Tfh cell population based on the expression of the marker CD57. CD57 is a glycoprotein expressed on a subset of GC CD4 + T cells that has been associated with an increased potential for GC B cell help (28). Our analysis revealed a statistically significant enrichment of Tfh cells in the LN cell suspensions of HIV + individuals compared with HCs (1.4% ± 0.6% versus 0.6% ± 0.4%, P = 0.0272) ( Figure 1C ), which is in line with previously described data (22). The frequency of CD57 + and CD57 -Tfh cells was also higher in HIV + individuals compared with HCs, with the difference being statistically significant for CD57 Figure 1B) . Similarly, frequency of Tfh cells expressing CXCR3, a chemokine receptor implicated in the trafficking of effector T cells into lymphoid organs (33) , was increased in HIV + individuals (Supplemental Figure 1 , A and C). Thus, LNs from ART-treated HIV + volunteers exhibit a potentially higher GC activity compared with HCs.
In the circulating lymphocytes, pTfh cells exhibit several functional properties reminiscent of GC Tfh cells. These features include a capacity for IL-21 secretion and the ability to promote B cell differentiation in vitro (26, 34 (37, 38) . We thus sought to determine whether baseline Tfh cell frequencies could predict the response to vaccination in terms of individual responses to influenza antigens for which antigenic probes were available. hemagglutinin inhibition assay (HIA) was performed as previously published (13) . We found that HIV + participants that mounted higher titers following vaccination (strong responders, with equal or greater than a 16-fold difference in titer versus the baseline as 4A. We found a significantly lower frequency of memory B cells in the LNs of infected individuals compared with controls (P = 0.0192/P = 0.0380, Mann-Whitney U test) (Supplemental Figure  3A) . Although not significant, a trend for a higher percentages of CD27 hi IgD lo or CD20 dim CD38 lo memory B cells after vaccination was found selectively in HIV + participants (Supplemental Figure 3A) , while no differences were found in the CD20 hi CD38 dim and CD20 lo CD38 hi compartments ( Figure 4B ). Furthermore, a significant induction of the IgG + Ki67 -population was observed after vaccination selectively in the CD20 dim CD38 lo memory B cell compartment of HIV + individuals (P = 0.0270, Mann-Whitney test) ( Figure 4C and Supplemental Figure 3B Figure 3B) . We also evaluated the percentages of circulating memory B cells before and after vaccination in the 2 donor groups using peripheral blood mononuclear Figure 5A ). In addition, Tfh and CD57 + Tfh cell frequencies at baseline, but not those of CD57 -Tfh cells, could predict the response to the less frequently encountered (39) influenza subtype B antigen ( Figure  5B ). However, no correlation was seen for Tfh cells and the more frequently encountered H1N1 antigen (Supplemental Figure 4A ) Figure  6A ). Further analysis of Tfh cell populations based on the expression of CD57 showed a reduction of both CD57 + and CD57 -subsets in HIV + donors, although the reduction was significant only in the CD57 -compartment ( Figure 6A ). No difference, however, was found when the relative frequencies were expressed as a percentage of the parental Tfh population (% of Tfh), a surrogate of the intrinsic capacity of the parental population to adopt the phenotypes under investigation (Supplemental Figure 5A ). The reduction in the frequency of Tfh cells within GCs was also confirmed using fluorescent confocal imaging ( Figure 6B ). These results demonstrate that vaccination is associated with an overall ue. A positive trend was observed between this population and influenza B antigen HIA titers (Supplemental Figure 4B ) and between CD20 dim CD38 lo B cells and antigen-specific B responses (Supplemental Figure 4B ), but this trend did not reach statistical significance. In aggregate, our data suggest that the baseline frequency of Tfh cells is a determinant for the development of vaccineinduced B cell responses toward the less frequently encountered influenza B antigen in treated HIV + infection. Vaccination is associated with a reduction in frequency of Tfh CD4 + T cells. Next, we investigated the effect of vaccination on draining LN CD4 + T cell dynamics. The relative frequencies of LN-derived CD4 + T cells were analyzed by applying a polychromatic flow cytometry-based assay and the gating scheme shown in Figure 1B . Comparative analysis revealed a significant reduc- . A tonsil treated with DNAse I (upper row) was also included in the assay to control for validity and staining specificity. Individual cells were detected using the nuclear dye JOPRO-1. (B) Cumulative histocytometry measurements for intrafollicular TUNEL + events before vaccination in HC (n = 3) and HIV + (n = 6) LNs. Different symbols and colors represent different patients. Symbol repetitions represent the different follicles within each tissue. P values were calculated using the MannWhitney t test. Original magnification, ×40.
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reduction of Tfh cells in draining LNs, a profile specifically found in HIV + individuals. Imaging analysis reveals a generalized reduction of Tfh cells. Tfh cell dynamics were further investigated by multiparameter histocytometry, a quantitative confocal imaging analysis that allows for the representation of confocal images in a 2D flow cytometric format (40, 41) . We employed a multiplexed assay to simultaneously detect 5 protein markers of interest, namely, CD20, Ki67, CD4, PD-1, CD57, and examined the numbers of Tfh cells in paired preand postvaccination LN samples from 3 HIV + individuals (Supplemental Table 1 ). GCs were defined based on the coexpression of CD20 and Ki67, as shown in Figure 7A . In agreement with our flow cytometry data, we found a reduction in the normalized (cells/ mm 2 ) numbers of Tfh cells in GCs after vaccination ( Figure 7B ). We also sought to investigate whether the loss of Tfh cells after vaccination could be associated with a loss of follicular architecture, as judged by the absence of FDC networks. In contrast with the prevaccination profile, no correlation was observed between the area of the FDC network (mm 2 ) and the absolute counts of Tfh cells after vaccination (Supplemental Figure 5B) . To complement our analysis, we also assessed whether the observed loss could arise from an infiltration of follicular CD8 (fCD8). We defined fCD8 T cells based on CXCR5 and CCR7expression (CCR7 
Ki67
-cells in paired pre-and postvaccination samples from HCs (n = 4) (white circles) and treated HIV + (n = 6) participants (black circles). P value determined by Mann-Whitney t test. 
Discussion
The interplay among follicular structure, Tfh cell dynamics, and B cell responses in chronic human infections is not well understood. We used LNs from cART-treated HIV + participants who received trivalent seasonal influenza vaccination. We applied multiparametric flow cytometry and advanced multiplexed confocal imaging to model these interactions. Where applicable, tonsils from unrelated HCs were also included in our microscopy studies. Although B cells constitute the largest cellular compartment in tonsils, imaging analysis of these tissues allows a topographic mapping of B cell follicular subareas (mantle zone, GCs, light and dark zones, and FDC network) of high resolution (36, 42) . Therefore, in our analyses, tonsils were used solely for histological comparison to matched areas from HC and HIV + LNs. We demonstrate that influenza vaccination alters the cellularity of draining LNs of HIV + persons in conjunction with the development of antigenspecific humoral responses. Understanding the dynamics supporting the development of antibody responses in HIV + persons is critical for the rational design of future vaccine strategies. However, follow-up biopsy studies in treated HIV + persons remain relatively scarce due to the difficulty in obtaining the necessary study material. From this standpoint, the data presented herein offer a unique and valuable insight into the tissue-specific changes that ensue following vaccination in treated HIV + persons, especially with regard to cellular subsets, such as FDCs, that are challenging to study ex vivo or in vitro due to their fragility in relation to mechanical and chemical stress (43, 44) .
In agreement with previous studies (22, 23), we report a significant (P = 0.0272) enrichment of Tfh cells (identified by high expression of PD-1 and CXCR5) in the LNs of HIV + patients compared with HCs. To further understand the possible role of Tfh cell subsets, we dissected this population based on the expression of the glycoprotein CD57, a marker of higher differentiation and senescence of circulating T cells (45) . In our study, both CD57 + and CD57
-Tfh populations were enriched in the follicles of HIV + individuals, particularly the CD57 + ones. It has been proposed that CD57 + Tfh cells may have an increased potential for GC B cell help (28, 46) . This is further substantiated by their relative positioning proximally to the DZ in "canonical" GCs (Supplemental Figure  2C) . Thus, it is plausible that HIV + individuals may harbor a differential potential for quicker vaccination-induced B cell mobilization at baseline compared with HCs given their higher CD57 + Tfh In our study, B cell follicles with intact FDC networks were more likely to harbor high frequencies of activated Tfh cells at baseline in an environment with overall higher immune activation, as supported by the increased rates of cell death found in the follicular areas of HIV + participants. FDCs form a relatively extended stromal cell network, representing a major producer of CXCL13 as well as growth factors, such as BAFF, IL-6, and IL-15, that are necessary for the proliferation and maintenance of B cells (51) (52) (53) (54) . The T cell area collagen deposition and fibrosis (4, 6, 55, 56) as well as the fibroblastic reticular cell (FRC) and FDC depletion that occur in HIV infection have been shown to profoundly affect the activation, population expansion, and effector function of viral antigen-specific T lymphocytes and to impair B cell viability and GC formation (6, 52, 54, 55, (57) (58) (59) (60) (61) . ART reverses this damage, but the kinetics of this reversal is highly variable among patients (7, 35, 62) . In addition, the loss of CD4 + T cells in HIV infection correlates with weaker antibody responses to influenza vaccination and impaired long-term serological memory to non-HIV anticell frequencies. However, how these higher frequencies might affect the development of antibody responses in the context of a skewed CD57 + Tfh distribution (Supplemental Figure 2C) is not known and warrants investigation. It is also currently unknown whether CD57 marks senescence for follicular CD4 + T cells, as in the case of circulating T cells (47) .
Our phenotypic analysis revealed further marked enrichment of Tfh cells displaying an ICOS hi SLAM hi or CXCR3 hi phenotype. Previous studies have shown that ICOS, SLAM, and CXCR3 could be positive regulators for the development of B cell responses (31, 48) . We have previously shown that SLAM hi Tfh cells from SIVinfected nonhuman primates produce a considerable amount of IL-10, a regulator of Tfh cell responses (49, 50) , while having a higher capacity for in vivo proliferation compared with SLAM lo Tfh cells (24). In addition to a higher frequency of Tfh cells expressing a SLAM hi phenotype, SLAM expression was higher per cell (as judged by the MFI, Supplemental Figure 1B The memory B cell compartment in HIV + infection is considerably harder to dissect due to the heterogeneity of the memory B cell populations (74) . Chronic HIV infection causes a skewing of the B cells toward a GC and plasma cell phenotype and a loss of total memory B cells both in the LNs (22) and in the circulation (75) . We found a lower frequency of memory CD27 + phenotyping in tissues using histocytometry. For the analysis, tissues were stained with anti-CD20 and anti-Ki67 for B cell follicle characterization as well as anti-PD-1, CD57, and CD4 for Tfh cells. The nuclear marker JOJO-1 was also included in the analysis to aid with computational cell segmentation. Confocal images were transformed to FlowJo files as previously described, and Tfh cell frequencies within individual GCs were calculated using FlowJo, as per the analysis example. GCs were defined by gating onto Ki67 + rich areas of high or dim CD20 expression before calculating the absolute numbers of Tfh cells within each GC gate. Before vaccination is shown in green, and after vaccination is shown in red. Graphics were generated using Singular (Fluidigm). HCs. A similar reduction in Tfh frequencies has also been reported for nonhuman primates (NHPs) receiving consecutive recombinant Env trimer prime-boost vaccinations (77) . It is therefore likely that this phenomenon may represent a physiological response to repeated antigenic stimulation. This finding is thus intriguing and warrants further investigation. One drawback of our study is the relatively small sample size, especially of the HIV-negative cohort, which precludes us from drawing further conclusions. Furthermore, enrolled HIV + donors presented CD4 + T cell counts and CD4 to CD8 ratios that may not be attainable by all patients on therapy. Therefore, some caution is warranted when translating such findings in the context of more divergent immunologic profiles. The lack of longitudinal LN samples also complicates the draw of mechanistic conclusions. These drawbacks are inherent to the nature and ethical considerations of our study protocol, but follow-up studies are warranted. Quantifying cell populations using imaging analysis of tissue sections also bears a risk for sampling error, as the representative value of a single imaged section cannot always be ascertained. In our case, however, similar profiles were obtained for the Tfh cell populations under investigation both by flow cytometry and tissue imaging histocytometry analysis. We therefore have crossvalidated our results using more than one experimental platform.
Our data also point to the heterogeneity of follicular dynamics, even within the same LN, as a biological parameter with a possible role in HIV pathogenesis and the development of immunogen-related antibody responses. What contributes to this heterogeneity is not well understood. To date, most of the work addressing follicular dynamics and vaccine efficacy has focused on the analysis of circulating Tfh cells and GC-related biomarkers, such as CXCL13 (78) (79) (80) (81) . However, our data revealed a dichotomy regarding the dynamics of bona fide Tfh cells and their blood counterparts, while no difference for blood levels of CXCL13 was found, at least in the patients under study (data not shown). Therefore, further studies to elucidate the LN immune dynamics after vaccination are needed. To this end, fine-needle aspiration (FNA) LN sampling in humans and longitudinal analysis of Tfh and GC B cell dynamics in NHP models would be of benefit (77) . The use of NHP-derived biopsies in particular could be highly informative, especially with regard to the role of stromal cells and overall spatial organization of immune subsets, parameters that the study of LN-derived cell suspensions alone cannot address. The existence of prior immunological memory is also important for the induction of de novo B cell responses in both HCs and HIV + individuals (82, 83) . However, the fate of memory Tfh cells, especially in a chronic retroviral infection such as HIV, is not known (84, 85) . Their tissue reactivation, possible retrafficking to GCs, and contribution to vaccine responses are all issues that can be addressed using NHP models. Our data suggest that responses toward individual vaccine components may have special merit as a readout in such studies. In addition, the observed reduction in Tfh cell frequency after vaccination implies that vaccine strategies employing prime-boost regimens may differ in their efficacy depending on the timing of Tfh cell kinetics.
In conclusion, we document that, in treated HIV + individuals, vaccination mobilizes relevant populations at the tissue level. Further studies in immunologically heterogeneous HIV + populations in these tissues. However, it is also plausible that sampling at day 14 after vaccination may not have been optimal for the detection and measurement of proliferating GC B cells. Under this scenario, an increase in the frequency of IgG + infection. The lack of an association between Tfh cells and H1N1 or H3N1 could be attributed to the relative contribution of the 2 influenza subtypes to the total disease burden. In 2015-2016, influenza type A accounted for nearly 66% to 78% of the influenza-positive cases reported, as compared with 22% to 34% for influenza B (39) . Therefore, a lower burden would make preexisting immunity to influenza B less likely and thus Tfh more relevant for this type of "primary" response. Alternatively, the prevalence of responses toward influenza type B at 2 weeks after vaccination could be indicative of differential kinetics in the processing and presentation of the 2 antigens. Preexisting immunity to influenza is also a plausible explanation for low vaccine responsiveness of HCs in our cohort. It should be noted, however, that even though some of our donors received a different formulation of the vaccine, there was no evidence of a differential segregation driven by formulation in our data set.
Interestingly, the assessment of T cell dynamics after vaccination revealed a reduction in the frequencies of Tfh cells, which did not appear to be fCD8 + T cell mediated. Although our gene analysis cannot address the manipulation of pro-or antiapoptotic pathways in Tfh cells after vaccination, the data indicate that CD57 + Tfh cells, which appear to be a more differentiated type of cell compared with their CD57 -counterparts ( Figure 8B ), could possibly be defective in HIV. In our study, CD57
+ Tfh cells could not upregulate some genes after vaccination as their counterparts in HCs did (Figure 8D) . A more comprehensive gene-signature analysis would be highly informative for this issue. We argue thus that a higher level of follicular activation may have rendered these cells susceptible to death through either infection or virus-independent activationinduced death (76) . The limited availability of study material, however, did not allow us to follow up on this hypothesis. One additional explanation for this phenomenon could also be that sampling at day 14 after vaccination was not optimal to detect newly generated Tfh cells that could balance the elimination of Tfh cells due to other mechanisms. This could be especially true in treated HIV + patients whose primary response kinetics may differ from those observed in Events were collected on a Fortessa X-50 flow cytometer (BD Immunocytometry Systems), and electronic compensation was performed with antibody capture beads (BD Biosciences). Data were analyzed using FlowJo version 9.9 (TreeStar) Confocal microscopy-histocytometry. Immunohistochemistry was performed on 5 to 10 μm tissue sections mounted on glass slides. H&E staining was performed at American Histolabs Inc. For confocal microscopy, tissue sections were deparaffinized and rehydrated with deionized water. Antigen retrieval was performed using Borg Decloaker RTU (Biocare Medical) in a decloaking chamber, with slides heated to 110°C for 15 minutes, or slides were treated with a proteinase K solution for 15 minutes for TUNEL staining according to the manufacturer's instructions (Click-IT Plus TUNEL Assay, Invitrogen, Thermo Fisher Scientific). Slides were then rinsed in PBS and permeabilized, and relevant primary antibodies were applied. A 2-hour incubation at room temperature followed. Slides were then washed in PBS, and corresponding Alexa Fluor dye-conjugated secondary antibodies were added for 2 hours at room temperature. Following incubation, slides were rinsed with PBS and stained with conjugated antibodies for 2 hours. Finally, JOJO-1 staining was applied, and slides were mounted for imaging. Confocal images were obtained on a Nikon C2si Confocal Running NIS-Elements AR with a ×40 (NA 1.3) objective and analyzed using Imaris software, version 8.4 (Bitplane). Spectral spillover between optical detection channels was corrected through live spectral unmixing using data acquired from samples singly stained with the respective fluorochromes. Quantitative analysis was performed using histocytometry. Images for histocytometry were acquired at a 512 × 512 pixel density, and the method was applied as previously published (40, 41) . In brief, 3D imaging data sets were segmented computationally after acquisition based on their nuclear staining signal, and average voxel intensities for all channels were generated in Imaris after isosurface generation. The extracted statistical data were then exported to Microsoft Excel, concatenated into a single commaseparated values format, and imported into FlowJo, version 10.3, for further analysis. Quantitative analysis was performed on individual follicles from 3 HIV + participants before and after vaccination. Single sections were analyzed. For histocytometrical Tfh cell enumeration, follicular areas were projected on a 2D plot format using the program FlowJo and gated based on CD20 intensity (CD20 hi-dim ) and Ki67. The same criteria were applied to all tissues. Follicular areas in regions displaying considerable tissue fragmentation or poorly resolved due to tissue folds or fat deposition that prevented accurate follicular mapping were not used in the analysis. The extent of FDC network area distribution (mm 2 ) was calculated using the program Imaris (BitPlane). Briefly, FDC stainings were segmented based on their mean intensity and FDC area mapping was performed by iso-surface generation. The analysis was performed for each follicle individually.
Real-time analysis by Fluidigm Biomark. Cryopreserved LN singlecell suspensions were thawed and rested in complete RPMI medium. Cells were labeled with monoclonal antibodies against CD3-APCH7 (BD Biosciences) (clone SK7), CD4-Cy55PE (Life Technologies) (clone S3.5), CD27-PC5 (Beckman-Coulter) (clone 1A4CD27), CD45RO-ECD (Beckman-Coulter) (clone UCHL1), CD8 BV785 will be required to fully understand how these dynamics can be manipulated for optimal vaccine efficacy. . Peripheral blood was collected within 24 hours of each LN sampling at T0 and T1 and in a subset also at 4 weeks (T2) after vaccination. Serum and plasma were stored at -80°C, and PBMCs and LMNCs were cryopreserved in liquid N 2 . Tonsils from HCs unrelated to the LN biopsy study participants were also used as controls. These specimens were discarded HIV -pathologic specimens.
Methods
Study participants.
Antibodies. Flow cytometry was performed using the following conjugated antibodies: CXCR5-PECy7 (clone MU5UBEE) (eBioscience); CD4-Cy55PE (clone S3.5) (Life Technologies); CD27-PC5 (clone 1A4CD27), CD45RO-ECD (clone UCHL1), CD19-ECD (clone J3-119) (Beckman Coulter); CD150-PE (clone 7D4), PD-1 BV711 (clone EH12.2H7), CD8-BV650 (clone SK1), CCR7-BV605 (clone G043H7), CD20-BV570 (clone 2H7), ICOS-PB (clone C398.4A), CXCR4-Cy7PE (clone 12G5), CD27-BV605 (clone O323) (BioLegend); CD183-APC (clone 1C6), CXCR5-FITC (clone RF8B2), IgM-Cy5PE (clone G20-127), IgG-APC (clone G18-145), Ki67-AlexaFluor 700 (clone B56) (BD Biosciences -Pharmingen); (f) IgD-PE (goat polyclonal) (Southern Biotech); (g) CD3-H7APC (clone SK7) (BD Biosciences: ). CD57-Alexa Fluor 700 (clone NK1, Thermo Fisher Scientific), CXCR4-FITC (clone 12G5, Thermo Fisher Scientific), CD3-BV785 (clone OKT3, BioLegend), CD95-BV421 (clone DX2, Thermo Fisher Scientific), and CD38-BV785 (clone HIT2, Thermo Fisher Scientific) were conjugated in house. Aqua Amine Viability Dye was obtained from Invitrogen (Molecular Probes, Life Technologies). For confocal microscopy, LN tissue sections were stained with the following primary and conjugated antibodies: IgD (clone EPR 6146, Abcam), CD4-Alexa Fluor 488 (goat polyclonal, R&D systems), CD20-eF615 (clone L26), PD-1 (goat polyclonal, R&D Systems), CD57 (clone NK1, Thermo Fisher Scientific), Ki67-Alexa Fluor 700 (clone B56, BD Bioscience), and JOJO-1 (Life Technologies).
Polychromatic flow cytometry. PBMCs or LMNCs (1 to 2 × 10 6 ), previously thawed and rested for 2 hours at 37°C, were incubated with the Amine Dye Aqua and surface stained with titrated amounts of antibodies against CD3, CD4, CD27, CD45RO, CCR7, CXCR5, CD150, CD183, PD-1, CD20, CD8, CD57, and ICOS for T cell phenotyping or against CD3, CD19, CD20, CD27, IgD, IgM, IgG, CD38, CD95, CXCR5, and (Biolegend) (clone SK1), TCRgd-FITC (BD Biosciences) (clone B1), CD56-FITC (BD Biosciences) (clone B159), CD19-PE (Biolegend) (clone HIB19), CD57-AF700 (Thermo Fisher Scientific) (clone NK1), CXCR5-PECy7 (eBioscience) (MU5UBEE), PD-1 BV711 (Biolegend) (clone EH12.2H7). Four-way sorting mode was used on FACS Aria II (BD Biosciences) to sort cell populations of interest. Twenty-five cells per subset were sorted in duplicate directly into 96-well microtiter plates containing CellsDirect One-Step PCR Buffer and pooled TaqMan gene expression assays (2× CellsDirect Reaction Mix 5 μl, Superscript III + Taq polymerase 0.5 μl, 0.2× TaqMan primer pool 2.5 μl, resuspension buffer 1 μl) (Thermo Fisher Scientific). After sorting, plates containing cells were immediately centrifuged (1,000 × g for 3 minutes) and kept on ice. Samples were subsequently transferred to PCR tubes and reverse transcription (RT) and target-specific preamplification were performed on a C1000 Thermal Cycler (Bio-Rad) as follows: 50°C for 20 minutes, 95°C for 2 minutes, 95°C for 15 seconds, 60°C for 4 minutes (last 2 steps repeated for 20 cycles). The resulting cDNA was diluted 1:1 with TE Buffer (10 mM Tris, 1 mM EDTA, pH 8.0) and stored at -20°C until further analysis. Previously amplified samples were loaded onto 96.96 dynamic array IFC (Fluidigm) as previously described (79) . The panel of TaqMan gene expression assays was qualified on human PBMCs and T lymphocytes as previously described (30-33, 75, 86) . Expression threshold (Et) values or log 2 expression was used for all analysis and was determined using the following formula: Et = 40 -Ct.
Statistics. Differences between groups were analyzed by Student's t test (2-tailed), Mann-Whitney test, or 1-way ANOVA according to data distribution. Correlations between 2 variables were evaluated by Pearson's correlation and linear regression. Analyses were performed using GraphPad Prism (GraphPad Software Inc.). P < 0.05 was considered significant, and results are presented as mean ± SD unless otherwise indicated.
Study approval. All protocols of this study involving human samples were reviewed and approved by the University of Miami Institutional Review Board. Signed informed consent was obtained in accordance with the Declaration of Helsinki. Tonsillar tissue was acquired from anonymized discarded pathologic specimens from the Children's National Medical Center (CNMC) under the auspices of the jci. 
